Current Clinical Trials

You may be eligible to take part in one of the many clinical trials underway at the UCI Alpha Stem Cell Clinic. By participating in a clinical trial, patients have access to leading-edge treatments and therapies long before they are available to the general public.

The more you know about clinical trials, the better informed you will be when deciding whether to participate in a specific trial. Click on the get more information buttons to see trial specifics on the Center for Clinical Trials website.

The UCI Center for Clinical Research oversees clinical trials for UCI Health and the UCI School of Medicine. Trials cover the full spectrum of conditions, from heart disease, neurological disorders, visual impairment, and more. Please visit the center's website to search for open clinical trials.

Questions or comments? Email us at stemcell@uci.edu or Fill Out Form

Current Clinical Trials

ApicBio Gene Therapy in ALS patients with SOD1 Mutations

Namita Goyal, M.D.

AskBio Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in Multiple System Atrophy

Nicolas Phielipp, M.D.

Aspen Neurosciences Developing a Trial-Ready Cohort of Parkinson Disease Patients

Nicolas Phielipp, M.D.

Audentes FORTIS Gene Transfer Study in Patients With Late Onset Pompe Disease

Tahseen Mozaffar, M.D.

Brain Neurotherapy Bio Open-Label Safety Study of Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in Parkinson’s Disease

Nicolas Phielipp, M.D.

Cartesian Descartes-08 Generalized Myasthenia Gravis Clinical Trial

Tahseen Mozaffar, M.D.

Cartesian Descartes-30 PHASE I/IIa study of Descartes-30 in Acute Respiratory Distress Syndrome Clinical Trial

Richard Lee, M.D.

Celularity CYNK-001 in Combination with Recombinant Human Interleukin-2 in Adults with Recurrent Glioblastoma GBM

Daniela Bota, M.D., Ph.D.

Direct Biologics, Evaluating the efficacy of EXOFLO in treating moderate to severe ARDS caused by COVID-19

Alpesh Amin, M.D.

Humacyte 005 Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-Threatening Vascular Trauma

Roy Fujitani, M.D.

Humacyte 007 Human Acellular Vessel in Subjects with End-Stage Renal Disease

Roy Fujitani, M.D.

Immunis, Inc, Open Label Use of IMM01-STEM In Patients With Muscle Atrophy Related to Knee Osteoarthritis

Dean Wang, M.D.

Regeneron Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in patients with symptomatic generalized Myasthenia Gravis

Ali Habib, M.D.

RegenXBio RGX-314 Gene Therapy in Participants with Neovascular or “Wet” Age-Related Macular Degeneration

Baruch Kuppermann, M.D.

Sangamo ST-920 a Gene Therapy in Subjects with Fabry Disease

Madeleine Pahl, M.D.

Spark SPK-3006 Late-Onset Pompe Disease Clinical Trial

Tahseen Mozaffar, M.D.

TIGENIX – Takeda Pharmaceuticals Crohn’s Disease: The ADMIRE-CDII Study

Nimisha K. Parekh, M.D., MPH

Ultragenyx UX053 for Glycogen Storage Disease Type III Clinical Trial

Tahseen Mozaffar, M.D.

Interested in a study?